↓ Skip to main content

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas

Overview of attention for article published in Acta Neuropathologica, February 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
281 Dimensions

Readers on

mendeley
185 Mendeley
Title
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II–III diffuse gliomas
Published in
Acta Neuropathologica, February 2015
DOI 10.1007/s00401-015-1398-z
Pubmed ID
Authors

Adriana Olar, Khalida M. Wani, Kristin D. Alfaro-Munoz, Lindsey E. Heathcock, Hinke F. van Thuijl, Mark R. Gilbert, Terri S. Armstrong, Erik P. Sulman, Daniel P. Cahill, Elizabeth Vera-Bolanos, Ying Yuan, Jaap C. Reijneveld, Bauke Ylstra, Pieter Wesseling, Kenneth D. Aldape

Abstract

Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of tumors. The role of tumor grade and mitotic index in patient outcome has not been evaluated following stratification by IDH mutation status. To address this, we interrogated 558 WHO grade II-III diffuse gliomas for IDH1/2 mutations and investigated the prognostic impact of WHO grade within IDH-mutant and IDH-wild type tumor subsets independently. The prognostic impact of grade was modest in IDH-mutant [hazard ratio (HR) = 1.21, 95 % confidence interval (CI) = 0.91-1.61] compared to IDH-wild type tumors (HR = 1.74, 95 % CI = 0.95-3.16). Using a dichotomized mitotic index cut-off of 4/1000 tumor cells, we found that while mitotic index was significantly associated with outcome in IDH-wild type tumors (log-rank p < 0.0001, HR = 4.41, 95 % CI = 2.55-7.63), it was not associated with outcome in IDH-mutant tumors (log-rank p = 0.5157, HR = 1.10, 95 % CI = 0.80-1.51), and could demonstrate a statistical interaction (p < 0.0001) between IDH mutation and mitotic index (i.e., suggesting that the effect of mitotic index on patient outcome is dependent on IDH mutation status). Patient age, an established prognostic factor in diffuse glioma, was significantly associated with outcome only in the IDH-wild type subset, and consistent with prior data, 1p/19q co-deletion conferred improved outcome in the IDH-mutant cohort. These findings suggest that stratification of grade II-III gliomas into subsets defined by the presence or absence of IDH mutation leads to subgroups with distinct prognostic characteristics. Further evaluation of grading criteria and prognostic markers is warranted within IDH-mutant versus IDH-wild type diffuse grade II-III gliomas as independent entities.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 185 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Netherlands 1 <1%
Nigeria 1 <1%
Unknown 182 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 11%
Researcher 20 11%
Student > Master 18 10%
Other 17 9%
Student > Doctoral Student 16 9%
Other 50 27%
Unknown 44 24%
Readers by discipline Count As %
Medicine and Dentistry 78 42%
Biochemistry, Genetics and Molecular Biology 15 8%
Neuroscience 13 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Agricultural and Biological Sciences 3 2%
Other 19 10%
Unknown 53 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 May 2015.
All research outputs
#15,334,706
of 22,808,725 outputs
Outputs from Acta Neuropathologica
#2,099
of 2,369 outputs
Outputs of similar age
#150,976
of 255,024 outputs
Outputs of similar age from Acta Neuropathologica
#20
of 27 outputs
Altmetric has tracked 22,808,725 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,369 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 255,024 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.